Haplotypic analyses of the IGF2-INS-TH gene cluster in relation to cardiovascular risk traits.

The IGF2-INS-TH genomic region has been implicated in various common disorders including the metabolic syndrome, type 2 diabetes and coronary heart disease (CHD). Here we present detailed haplotype analysis of 2743 males 51-62 years old in relation to body weight and composition, blood pressure (BP) and plasma triglycerides (TG). Use of the total data set was complicated by the number of loci typed, missing data, multi-allelic markers and continuous trait phenotypes. Different algorithms and subsets of the data were analysed using the programmes haplotype trend regression, haplo.score, evolutionary-based haplotype analysis package and Phase, in conjunction with SPSS. Ten haplotypes designated in frequency order *1(20.0%) to *10(3.4%) represented 89% of all haplotypes. Haplotype *5 protected against obesity. Haplotype *4 carriers exhibited elevated BP and fat mass, haplotype *6 was associated with raised plasma TG levels. Haplotype *8 also showed similar magnitude effects as *4. These cohort trait analyses and detailed haplotypic analyses enable integration with published case data. Haplotypes *4, *6 and *8 are the only INS VNTR class III-bearing haplotypes, although differing in flanking haplotype, whereas *5 displays unique features in all three genes (with significant commonality with type 1 diabetes-predisposition haplotypes). We propose that long repeat insertion in the insulin gene promoter ('class III'), reported to result in low insulin production, predisposes to the metabolic syndrome features of elevated BP, fat mass or TG level, therefore appearing more frequently in type 2 diabetic, polycystic ovary syndrome and CHD cases. The functional element(s) of *5 for weight-lowering could reside in any of the three genes.

[1]  P. Arner,et al.  The antilipolytic effect of insulin in human adipose tissue in obesity, diabetes mellitus, hyperinsulinemia, and starvation. , 1981, Metabolism: clinical and experimental.

[2]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.

[3]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias , 1990, The Lancet.

[4]  C Summers,et al.  Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). , 1989, Nucleic acids research.

[5]  S. Humphries,et al.  Electrophoresis for genotyping: microtiter array diagonal gel electrophoresis on horizontal polyacrylamide gels, hydrolink, or agarose. , 1994, Analytical biochemistry.

[6]  G. Hitman,et al.  Diabetic hypertriglyceridaemia and related 5' flanking polymorphism of the human insulin gene. , 1984, British medical journal.

[7]  Jacqueline P Mitchell,et al.  Comparison of Novel Hemostatic Factors and Conventional Risk Factors for Prediction of Coronary Heart Disease , 2000, Circulation.

[8]  M. Taskinen,et al.  Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects. , 1998, Diabetes.

[9]  D. Schaid,et al.  Score tests for association between traits and haplotypes when linkage phase is ambiguous. , 2002, American journal of human genetics.

[10]  M. McCarthy,et al.  Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome , 1997, The Lancet.

[11]  E. Boerwinkle,et al.  Ionizing radiation and genetic risks. VI. Chronic multifactorial diseases: a review of epidemiological and genetical aspects of coronary heart disease, essential hypertension and diabetes mellitus. , 1999, Mutation research.

[12]  P. Munroe,et al.  Genetics of hypertension. , 2000, Current opinion in genetics & development.

[13]  Kathryn Roeder,et al.  Evolutionary‐based association analysis using haplotype data , 2003, Genetic epidemiology.

[14]  Sylvia Richardson,et al.  Markov Chain Monte Carlo in Practice , 1997 .

[15]  R. Chakraborty,et al.  Ionizing radiation and genetic risks. XIII. Summary and synthesis of papers VI to XII and estimates of genetic risks in the year 2000. , 2000, Mutation research.

[16]  E. Snyder,et al.  The human obesity gene map: the 2002 update. , 2003, Obesity research.

[17]  J. Mallet,et al.  Quantitative effects on gene silencing by allelic variation at a tetranucleotide microsatellite. , 2001, Human molecular genetics.

[18]  J. Todd,et al.  Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus , 1997, Nature Genetics.

[19]  N. E. Morton,et al.  The first linkage disequilibrium (LD) maps: Delineation of hot and cold blocks by diplotype analysis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Monticelli,et al.  Polymorphism at the 5‘ end flanking region of the insulin gene is associated with reduced insulin secretion in healthy individuals , 1988, European journal of clinical investigation.

[21]  Hongyu Zhao,et al.  Haplotype analysis in population genetics and association studies. , 2003, Pharmacogenomics.

[22]  Tom R. Gaunt,et al.  SNP genotyping by combination of 192-well MADGE, ARMS and computerized gel image analysis. , 2000, BioTechniques.

[23]  Tom R. Gaunt,et al.  Positive associations between single nucleotide polymorphisms in the IGF2 gene region and body mass index in adult males. , 2001, Human molecular genetics.

[24]  Leif Andersson,et al.  A paternally expressed QTL affecting skeletal and cardiac muscle mass in pigs maps to the IGF2 locus , 1999, Nature Genetics.

[25]  C. Bouchard,et al.  Insulin-like growth factor 2 (IGF2 ) and IGF-binding protein 1 (IGFBP1) gene variants are associated with overfeeding-induced metabolic changes , 2001, Diabetologia.

[26]  P. Talmud,et al.  Genetic determinants of plasma triglycerides: Impact of rare and common mutations , 2001, Current atherosclerosis reports.

[27]  S. Wannamethee,et al.  Body weight: implications for the prevention of coronary heart disease, stroke, and diabetes mellitus in a cohort study of middle aged men , 1997, BMJ.

[28]  Sandra D. O'Dell,et al.  Evidence of multiple causal sites affecting weight in the IGF2-INS-TH region of human chromosome 11 , 2002, Human Genetics.

[29]  J. Thyberg,et al.  Shortened life span, bradycardia, and hypotension in mice with targeted expression of an Igf2 transgene in smooth muscle cells. , 2003, Endocrinology.

[30]  C Zapata,et al.  Spectrum of nonrandom associations between microsatellite loci on human chromosome 11p15. , 2001, Genetics.

[31]  J. Todd,et al.  Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus , 1995, Nature Genetics.

[32]  G. King,et al.  Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo : a specific vascular action of insulin. , 2000, Circulation.

[33]  I. Robinson,et al.  High plasma insulin-like growth factor-II and low lipid content in transgenic mice: measurements of lipid metabolism. , 1994, The Journal of endocrinology.

[34]  S. Tilghman,et al.  Deletion of a nuclease-sensitive region between the Igf2 and H19 genes leads to Igf2 misregulation and increased adiposity. , 2001, Human molecular genetics.

[35]  P. Kopelman.  Obesity as a medical problem , 2000, Nature.

[36]  Pascal Leroy,et al.  An imprinted QTL with major effect on muscle mass and fat deposition maps to the IGF2 locus in pigs , 1999, Nature Genetics.

[37]  E. Boerwinkle,et al.  Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism. , 2000, American journal of human genetics.

[38]  Tom R. Gaunt,et al.  Manual 768 or 384 well microplate gel 'dry' electrophoresis for PCR checking and SNP genotyping. , 2003, Nucleic acids research.

[39]  Peter H. Westfall,et al.  Testing Association of Statistically Inferred Haplotypes with Discrete and Continuous Traits in Samples of Unrelated Individuals , 2002, Human Heredity.

[40]  D. S. Rath,et al.  Tetranucleotide repeat polymorphism at the human tyrosine hydroxylase gene (TH). , 1991, Nucleic acids research.

[41]  I. Day,et al.  Associations of IGF2 ApaI RFLP and INS VNTR class I allele size with obesity , 1999, European Journal of Human Genetics.

[42]  D. Dunger,et al.  Low circulating IGF-II concentrations predict weight gain and obesity in humans. , 2003, Diabetes.

[43]  C. Bouchard,et al.  A genomewide linkage scan for abdominal subcutaneous and visceral fat in black and white families: The HERITAGE Family Study. , 2002, Diabetes.

[44]  F. Massey.  The Kolmogorov-Smirnov Test for Goodness of Fit , 1951 .

[45]  Amanda J. Wilson,et al.  Transmission ratio distortion at the INS-IGF2 VNTR , 1999, Nature Genetics.

[46]  D. Clayton,et al.  Positive association of tyrosine hydroxylase microsatellite marker to essential hypertension. , 1998, Hypertension.

[47]  Camillo Ricordi,et al.  The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes , 1997, Nature Genetics.

[48]  G. Lathrop,et al.  Insulin-IGF2 region on chromosome 11p encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility , 1991, Nature.

[49]  I. Day,et al.  Higher resolution microplate array diagonal gel electrophoresis: Application to a multiallelic minisatellite , 2000, Human mutation.

[50]  J Buard,et al.  Influence of allele lineage on the role of the insulin minisatellite in susceptibility to type 1 diabetes. , 2000, Human molecular genetics.

[51]  J. Weber,et al.  Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. , 1989, American journal of human genetics.

[52]  S. Humphries,et al.  Apal polymorphism in insulin-like growth factor II (IGF2) gene and weight in middle-aged males , 1997, International Journal of Obesity.

[53]  Gregory S. Barsh,et al.  Genetics of body-weight regulation , 2000, Nature.

[54]  M. Hurles,et al.  Global haplotype diversity in the human insulin gene region. , 2003, Genome research.

[55]  P. Donnelly,et al.  A new statistical method for haplotype reconstruction from population data. , 2001, American journal of human genetics.

[56]  J. Todd,et al.  Human type 1 diabetes and the insulin gene: principles of mapping polygenes. , 1996, Annual review of genetics.

[57]  M. Taskinen,et al.  Metabolic basis of hypotriglyceridemic effects of insulin in normal men. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[58]  J. Cooper,et al.  Increased Activation of the Haemostatic System in Men at High Risk of Fatal Coronary Heart Disease , 1996, Thrombosis and Haemostasis.

[59]  J. Todd,et al.  INS VNTR allelic variation and dynamic insulin secretion in healthy adult non‐diabetic Caucasian subjects , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[60]  R. Eckel,et al.  Insulin regulation of lipoprotein lipase in cultured isolated rat adipocytes. , 1984, Endocrinology.

[61]  Francisco M. de la Vega,et al.  On the Power to Detect SNP/Phenotype Association in Candidate Quantitative Trait Loci Genomic Regions: A Simulation Study , 2002, Pacific Symposium on Biocomputing.

[62]  I. Day,et al.  Microplate array diagonal gel electrophoresis for cohort studies of microsatellite loci. , 2002, BioTechniques.

[63]  A. Jindra.  Association Analysis of Two Tyrosine Hydroxylase Gene Polymorphisms in Normotensive Offspring from Hypertensive Families , 2000, Blood pressure.

[64]  C. Sartori,et al.  Insulin as a vascular and sympathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. , 1997, Circulation.

[65]  S. Haffner.  Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance. , 2002, The American journal of cardiology.

[66]  L. Jin,et al.  Identification of repeat sequence heterogeneity at the polymorphic short tandem repeat locus HUMTH01[AATG]n and reassignment of alleles in population analysis by using a locus-specific allelic ladder. , 1993, American journal of human genetics.